Frequently Asked Questions - Therapy Questions

Techniques designed to enhance the mind's capacity to affect the biological functioning of the body.

Additional information
Mind body therapies include psychological, emotional, social, expressive and spiritual approaches. Energy treatments based on putative human energy fields (i.e. fields which have yet to be measured) are listed as mind-body interventions.
 

substances found in nature that usually have a pharmacological or biological activity.

Additional information
Natural products originate from sources like plants, animals, bacteria, fungi. The products listed are not modified.
 

Administration of manipulated self or non-self human cells to patients

Additional information
Cell-based therapies are divided into 2 sub-categories:
Autologous cell therapies cover treatments in which white blood cells are isolated from a patient, manipulated in the laboratory and subsequently administered to the patient.
Heterologous cell therapies cover treatments in which non-self human cells are manipulated in the laboratory and subsequently administered to the patient.
 

Medical use of high-energy radiation to kill cancer cells and reduce tumor size. 
 
Additional information

Radiotherapy is a treatment method using radiation from x-rays, gamma rays, neutrons, protons, and other sources. Methods and subtypes of radiotherapy listed are mentioned in the ESMO clinical practice guidelines.
 

Procedures involving instrumental means to investigate or treat a cancer, or to improve body’s functions or appearance. Generally, a surgical intervention involves an incision.
 
Additional information
Surgical interventions listed are interventions mentioned in the ESMO clinical practice guidelines.
 

Anti-cancer drugs with market authorization in the USA or in countries of the European Union.
 
Additional information
The Anticancer Fund considers a drug as registered if:
-           The drug is approved by the European Medicine Agency, by the US Food and Drug Administration or by the                       authority of one of the following countries: Belgium, France, Switzerland and the United Kingdom.
-          The drug is approved for the treatment of at least one type of cancer.